Fig. 7. Effect of PFCE-C25 NEs on an LLC metastatic model after the depletion of CD8⁺ T cells or CD4⁺ T cells in mice.

(A) Schematic diagram of the depletion and treatment regimen. (B) Flow cytometry results for CD8⁺ T cell– or CD4⁺ T cell–depleted mice. (C) MRI results for immunotherapy monitoring. The red arrow points to the tumor. (D) Mouse body weight measurements (n = 3). (E) Log-rank survival curve analysis.